Did you know colon cancer is the third most commonly diagnosed cancer and the second leading cause of cancer death for both men and women in the U.S.? Determined to make a dent in these statistics, the Intel International Science and Engineering Fair (Intel ISEF) 2013 finalist Keven Stonewall used findings from immunology studies on other kinds of cancer to develop a promising experimental vaccine for colon cancer.
To learn more about Keven visit: intel.com/content/www/us/en/corporate-responsibility/better-future/preventing-colon-cancer.html
Loading more stuff…
Hmm…it looks like things are taking a while to load. Try again?